NEW YORK (GenomeWeb News) – Ohio State University today announced it has licensed to Microlin Bio almost 100 issued and pending microRNA patents for the potential development of cancer diagnostics and treatments.

Microlin also licensed a novel nucleic acid delivery technology from OSU to deliver new therapies to cancer patients. The new therapies would be based on the miRNA patents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.